HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The 825C/T polymorphism of G-protein beta3 subunit gene and risk of ischaemic stroke.

Abstract
In this study, we investigated the association of G protein beta3 subunit gene (GNB 3) C825T polymorphism with ischaemic stroke and its subtypes in the Chinese Han population in a large case-control study. A total of 990 ischemic stroke patients and 1124 controls were recruited from six medical centres in China. Genotype was determined by polymerase chain reaction and restriction fragment length polymorphism (RFLP) assay. Logistic regression analysis was performed to identify the independent risk factors for stroke. The frequency of 825T carriers is significantly higher in cerebral thrombosis in male subjects (OR=1.35, 95% CI, 1.01-1.82, P=0.046). After further adjustment with traditional risk factors to stroke, the association is not significant. In conclusion, the GNB3 825T allele is not an independent risk factor to ischaemic stroke in the Chinese population.
AuthorsL Zhang, H Zhang, K Sun, Y Song, R Hui, X Huang
JournalJournal of human hypertension (J Hum Hypertens) Vol. 19 Issue 9 Pg. 709-14 (Sep 2005) ISSN: 0950-9240 [Print] England
PMID15920455 (Publication Type: Journal Article, Multicenter Study, Research Support, Non-U.S. Gov't)
Chemical References
  • G-protein beta3 subunit
  • Cytosine
  • Heterotrimeric GTP-Binding Proteins
  • Thymine
Topics
  • Aged
  • Asian People (genetics)
  • Brain Ischemia (genetics)
  • Case-Control Studies
  • Cytosine
  • Female
  • Gene Frequency
  • Genetic Predisposition to Disease
  • Heterotrimeric GTP-Binding Proteins (genetics)
  • Humans
  • Male
  • Middle Aged
  • Polymorphism, Genetic
  • Stroke (genetics)
  • Thymine

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: